Journal of Dental Science and Medicine
Open Access

Oral cancer, including cancers of the oral cavity and oropharynx, is a major health concern worldwide. According to the World Health Organization (WHO), oral cancer ranks as the 6th most common malignancy globally, with the majority of cases occurring in developing countries. The disease typically presents at advanced stages, leading to high rates of morbidity and poor survival. Early detection of oral cancer significantly improves the chances of successful treatment and survival, but current diagnostic methods, such as biopsy and imaging, are often invasive, costly, and time-consuming [1-4].

In recent years, research has shifted towards identifying non-invasive biomarkers in saliva, which could be used for the early detection of oral cancer. Saliva is easily accessible, contains a variety of molecules that reflect the physiological and pathological status of the body, and can be collected in a non-invasive manner. As a result, salivary biomarkers are emerging as a promising tool for the detection and monitoring of oral cancer.

Saliva as a Diagnostic Tool

Saliva is a complex fluid containing water, electrolytes, proteins, enzymes, hormones, and metabolites. It is secreted by the salivary glands and plays a crucial role in oral health, digestion, and protection of oral tissues. Importantly, the composition of saliva can be influenced by both local factors (such as oral infections, inflammation, or malignancies) and systemic conditions (such as diabetes or hormonal imbalances). Because saliva is in direct contact with oral mucosal tissues, it has the potential to serve as a mirror for detecting changes in the molecular environment associated with diseases, including oral cancer.

Salivary biomarkers are molecules that can be measured in saliva and indicate the presence, progression, or recurrence of disease. These biomarkers can be proteins, nucleic acids, metabolites, or microRNAs, among others. They are of particular interest in oral cancer research due to their potential to serve as early indicators of malignancy, enabling timely diagnosis and intervention [4].

Types of Salivary Biomarkers for Oral Cancer

Several types of salivary biomarkers have been identified as potential indicators for oral cancer. These biomarkers can be broadly categorized into proteins, nucleic acids, and other small molecules such as metabolites and lipids. Below are some of the most studied biomarkers in the context of oral cancer detection:

1. Proteins and Enzymes

Proteins and enzymes in saliva are among the most widely studied biomarkers for oral cancer. Several proteins exhibit altered levels in the saliva of oral cancer patients. These include:

Cyclooxygenase-2 (COX-2): COX-2 is an enzyme involved in the production of prostaglandins, which are implicated in inflammation and tumorigenesis. Elevated COX-2 levels have been associated with oral squamous cell carcinoma (OSCC).

Matrix Metalloproteinases (MMPs): MMPs are enzymes that degrade extracellular matrix components and facilitate tumour invasion. Increased MMP levels in saliva have been linked to the presence and progression of oral cancers [5].

Tumour Necrosis Factor-alpha (TNF-α): TNF-α is a cytokine that plays a role in inflammation and immune response. Elevated TNF-α levels in saliva have been suggested as a marker for oral cancer development.

Salivary Proteins like Statherian and S100: These proteins are often altered in cancerous conditions and can serve as markers for oral cancers. Changes in their expression can reflect early cellular transformations associated with malignancy.

2. Nucleic Acids (DNA and RNA)

Nucleic acids, such as DNA and RNA, are important biomarkers for oral cancer detection. Cancer cells release abnormal DNA and RNA into the bloodstream and surrounding tissues, including the oral cavity. Key examples include:

Salivary DNA Methylation Patterns: Aberrant DNA methylation is a hallmark of many cancers. Studies have shown that altered methylation patterns in saliva can serve as reliable biomarkers for early oral cancer detection, even before the appearance of clinical symptoms.

MicroRNAs (miRNAs): miRNAs are small non-coding RNAs that regulate gene expression. Several miRNAs are differentially expressed in the saliva of patients with oral cancer. For example, miRNA-21 and miRNA-155 have been found to be upregulated in the saliva of individuals with OSCC.

Human Papillomavirus (HPV) DNA: HPV infection, particularly with high-risk strains like HPV-16, is a major risk factor for oropharyngeal cancer. Detecting HPV DNA in saliva could be an important biomarker for early oral and oropharyngeal cancer diagnosis [6].

3. Metabolites and Other Small Molecules

Metabolites are small molecules that result from cellular metabolic processes and can provide insight into disease states. Alterations in metabolic pathways are common in cancer cells, leading to changes in the metabolic profile of the saliva. Key examples include:

Lactate and Pyruvate: Increased levels of lactate and pyruvate in saliva have been linked to oral cancer. These molecules are involved in anaerobic metabolism, which is often upregulated in cancer cells.

Acetate and Acetone: Volatile organic compounds like acetate and acetone can also serve as potential biomarkers for oral cancer. Their altered presence in saliva may reflect changes in cellular metabolism and cancer progression.

Amino Acids: Elevated or reduced levels of certain amino acids, such as glutamine or phenylalanine, have been associated with oral cancer. These changes could be useful for developing diagnostic tests based on the amino acid profile in saliva.

Clinical Applications of Salivary Biomarkers

Salivary biomarkers have significant potential in the early detection, diagnosis, and monitoring of oral cancer. Their application can be seen in several areas:

1. Early Detection and Diagnosis

Salivary biomarkers provide an opportunity for early oral cancer detection, which is critical for improving patient prognosis. Using non-invasive saliva tests, clinicians can identify potential biomarkers of oral cancer in high-risk populations (e.g., tobacco and alcohol users, HPV-positive individuals). This can enable earlier intervention before the disease progresses to advanced stages, improving the likelihood of successful treatment [7].

2. Monitoring Disease Progression and Recurrence

Saliva-based tests can be used to monitor the progression of oral cancer and detect recurrence after treatment. Regular monitoring of salivary biomarkers allows for the identification of subtle changes that may indicate cancer progression or metastasis. This approach can be particularly beneficial for patients who have undergone surgery, radiation, or chemotherapy and are at risk for relapse.

3. Personalized Treatment

Salivary biomarkers can aid in the development of personalized treatment plans for oral cancer patients. By analysing the molecular characteristics of an individual’s oral cancer through saliva, clinicians can better understand the tumour’s biology and select the most effective treatment modalities, potentially improving therapeutic outcomes.

4. Cost-Effectiveness and Patient Compliance

Traditional diagnostic methods, such as biopsies and imaging, can be invasive, costly, and uncomfortable for patients. Saliva collection, on the other hand, is a non-invasive, inexpensive, and patient-friendly alternative. This approach improves patient compliance, reduces healthcare costs, and enables routine screening for oral cancer.

Challenges and Limitations

Despite the promising potential of salivary biomarkers, several challenges remain

Sensitivity and Specificity: While salivary biomarkers show promise, their sensitivity and specificity must be further improved to reduce the risk of false positives or negatives in clinical settings.

Standardization: There is a lack of standardization in the methods used for collecting, processing, and analysing saliva samples. Consistent protocols need to be established to ensure reliable results across different settings.

Clinical Validation: While numerous biomarkers have been identified, many of them have not yet undergone rigorous clinical validation. Further research and clinical trials are needed to confirm the diagnostic and prognostic value of these biomarkers [8-10].

Future Directions

Multi-Biomarker Panels: A single biomarker may not provide sufficient sensitivity or specificity for oral cancer detection. Future research should focus on developing multi-biomarker panels, combining proteins, nucleic acids, and metabolites, to increase the accuracy of oral cancer detection.

Integration with Other Diagnostic Tools: Combining salivary biomarkers with other diagnostic techniques, such as imaging and molecular profiling, could lead to more accurate and comprehensive oral cancer detection and monitoring.

Personalized Saliva-based Diagnostics: Advances in genomics and bioinformatics could pave the way for personalized saliva-based diagnostic tools that tailor the diagnostic process to the individual patient, improving early detection and treatment outcomes.

Conclusion

Salivary biomarkers offer a promising, non-invasive approach to the early detection, diagnosis, and monitoring of oral cancer. With their potential to provide quick, cost-effective, and patient-friendly diagnostics, salivary biomarkers could revolutionize the way oral cancer is detected and managed. While challenges remain in terms of standardization, sensitivity, and clinical validation, the future of saliva-based diagnostics holds great promise for improving the outcomes of oral cancer patients worldwide.

1. Frutos FJ, Pérez R, Escolano O, Rubio A, Gimeno A, et al. (2012)Remediation trials for hydrocarbon-contaminated sludge from a soil washing process: evaluation of bioremediation technologies.J Hazard Mater 199:262-27.

Indexed at, Google Scholar, Crossref

2. Frutos FJ, Escolano O, García S, Babín MM, Fernández MD (2010)Bioventing remediation and ecotoxicity evaluation of phenanthrene-contaminated soil.J Hazard Mater 183: 806-813.

Indexed at, Google Scholar, Crossref

3. Sui H, Li X (2011)Modeling for volatilization and bioremediation of toluene-contaminated soil by bioventing.Chin J Chem Eng 19: 340-348.

Indexed at, Google Scholar, Crossref

4. Khudur LS, Shahsavari E, Miranda AF, Morrison PD, Nugegoda DD, et al. (2015)Evaluating the efficacy of bioremediating a diesel-contaminated soil using ecotoxicological and bacterial community indices.Environ Sci Pollut Res 22: 14819.

Indexed at, Google Scholar, Crossref

5. Whelan MJ, Coulon F, Hince G, Rayner J, McWatters R, et al. (2015)Fate and transport of petroleum hydrocarbons in engineered biopiles in polar regions.Chemosphere 131: 232-240.

Indexed at, Google Scholar, Crossref

6. Dias RL, Ruberto L, Calabró A, Balbo AL, Panno MT, et al. (2015)Hydrocarbon removal and bacterial community structure in on-site biostimulated biopile systems designed for bioremediation of diesel-contaminated Antarctic soil.Polar Biol 38: 677-687.

Google Scholar, Crossref

7. Coulon F, Al-Awadi M, Cowie W, Mardlin D, Pollard S, et al. (2010)When is a soil remediated? Comparison of biopiled and windrowed soils contaminated with bunker-fuel in a full-scale trial.Environ Pollut158: 3032-3040.

Indexed at, Google Scholar, Crossref

8. Hobson AM, Frederickson J, Dise NB (2005)CH4 and N2O from mechanically turned windrow and vermincomposting systems following in-vessel pre-treatment.Waste Manag 25: 345-352

Indexed at, Google Scholar, Crossref

9. Mohan SV, Sirisha K, Rao NC, Sarma PN, Reddy SJ (2004)Degradation of chlorpyrifos contaminated soil by bioslurry reactor operated in sequencing batch mode: bioprocess monitoring.J Hazard Mater 116: 39-48.

Indexed at, Google Scholar, Crossref

10. Nikolopoulou M, Pasadakis N, Norf H, Kalogerakis N (2013)Enhanced ex situ bioremediation of crude oil contaminated beach sand by supplementation with nutrients and rhamnolipids.Mar Pollut Bull 77: 37-44.

Indexed at, Google Scholar, Crossref